List view / Grid view
Thermo Fisher Scientific Inc., the world leader in serving science, announced a line-up of new products at the 2017 Pittcon Conference and Exhibition that enable application-specific workflows for pharma/biopharma, materials science, and environmental and food safety markets.
20 March 2017 | By Shimadzu Scientific Instruments
Shimadzu Scientific Instruments (SSI) announces the release of the AIM-9000 infrared microscope. With automated analysis functions and an enhanced wide field camera option, the microscope enables analysts of all experience levels to observe, measure, and analyse micro samples quickly and efficiently...
20 March 2017 | By Waters Corporation
Waters Corporation announced the launch of Empower® Cloud, a cloud deployable, compliance ready enterprise Chromatography Data Software (CDS)...
20 March 2017 | By Bruker
Bruker is showcasing a selection of innovative high-performance systems and high-value analytical solutions at Pittcon 2017, with an emphasis on pharma and applied markets, as well as on nano-materials research and microscopy...
20 March 2017 | By Niamh Marriott, Junior Editor
A research team reviewed the efficacy, safety, and adherence to fixed-dose combinations (FDCs) of drugs versus single-drug formulations...
20 March 2017 | By Merck Millipore
Merck, a leading science and technology company, announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation...
20 March 2017 | By Niamh Marriott, Junior Editor
Research published by BioMed Central’s open access journal AIDS Research and Therapy has investigated the use of lubricants...
20 March 2017 | By Niamh Marriott, Junior Editor
Debiopharm International, a Swiss-based company, part of Debiopharm Group, announced that triptorelin 6-month formulation (Decapeptyl and Pamorelin 22.5 mg) received approval for the treatment of central precocious puberty (CPP) in 22 European countries, where the 6-month formulation has already been registered for the treatment of prostate cancer. Triptorelin is the…
Thermo Fisher Scientific Inc., the world leader in serving science, announced that it has acquired Core Informatics, which provides a leading cloud-based platform supporting scientific data management.
17 March 2017 | By Honeywell
Honeywell announced the launch of its first series of Hydranal™ double-certified reference materials (CRM) for Karl Fischer Titration...
17 March 2017 | By Honeywell
Honeywell announced the launch of a new business, Honeywell Research Chemicals, that will now include several brands and solvent and inorganic chemical products that were acquired from Sigma-Aldrich in December 2015...
17 March 2017 | By F.P.S. Food and Pharma Systems Srl
At Interphex (21-23 March in New York, USA), FPS will show his last innovations in micronization and milling technologies, for pharmaceutical, cosmetic and chemical applications...
17 March 2017 | By Niamh Marriott, Junior Editor
In a new study, advanced metastatic melanoma cancer patients that had become resistant to their BRAF-targeted treatment were given a retreatment...
17 March 2017 | By Niamh Marriott, Junior Editor
AstraZeneca’s Phase III SOLO-2 trial demonstrated a significant improvement in progression-free survival (PFS) in germline BRCA-mutated (gBRCA), platinum-sensitive, relapsed ovarian cancer patients treated with Lynparza (olaparib) tablets (300mg twice daily) compared with placebo in the maintenance setting. The trial met its primary endpoint of investigator assessed PFS (HR 0.30; 95%…
16 March 2017 | By Syrris
Syrris’ state-of-the-art Orb batch reactors are designed by chemists for chemists, ensuring they perfectly meet the demands of your work...
